Should Acetazolamide Be the First-Line Treatment for Patients with Idiopathic Intracranial Hypertension?

David I. Kaufman, Deborah I. Friedman

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Should Acetazolamide Be the First-Line Treatment for Patients with Idiopathic Intracranial Hypertension?'. Together they form a unique fingerprint.